The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
Open accessAbstract
The beneficial actions of nonsteroid anti-inflammatory drugs (NSAID) can be associated with inhibition of cyclo-oxygenase (COX)-2 whereas their harmful side effects are associated with inhibition of COX-1. Here we report data from two related assay systems, the human whole blood assay and a modified human whole blood assay (using human A549 cells as a source of COX-2). This assay we refer to as the William Harvey Modified Assay. Our aim was to make meaningful comparisons of both classical NSAIDs and newer COX-2-selective compounds. These comparisons of the actions of >40 NSAIDs and novel COX-2-selective agents, including celecoxib, rofecoxib and diisopropyl fluorophosphate, demonstrate a distribution of compound selectivities toward COX-1 that aligns with the risk of serious gastrointestinal complications. In conclusion, this full in vitro analysis of COX-1/2 selectivities in human tissues clearly supports the theory that inhibition of COX-1 underlies the gastrointestinal toxicity of NSAIDs in man.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Self-citationVane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Self-citationGoodman and Gilman's The Pharmacological Basis of Therapeutics
Hastings, R. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540120077042 · Cited by 2,371
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659
Self-citationHawkey, C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12154-2 · Cited by 1,173
Henry, D., Lim, L. L.-Y., Rodriguez, L. A. G., Gutthann, S. P., Carson, J. L., Griffin, M., Savage, R., Logan, R., Moride, Y., Hawkey, C., et al. (1996) · BMJ · doi:10.1136/bmj.312.7046.1563 · Cited by 827
Patrignani, P., Panara, M. R., Greco, A., Fusco, O., Natoli, C., Iacobelli, S., Cipollone, F., Ganci, A., Créminon, C., & Maclouf, J. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24061-7 · Cited by 518
Reuter, B. K., Asfaha, S., Buret, A., Sharkey, K. A., & Wallace, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119013 · Cited by 423
Clinical Pharmacokinetics of Diclofenac: Therapeutic Insights and Pitfalls
Davies, N. M., & Anderson, K. E. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733030-00003 · Cited by 398
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
Whittle, B. J. R., Higgs, G. A., Eakins, K. E., Moncada, S., & Vane, J. R. (1980) · Nature · doi:10.1038/284271a0 · Cited by 392
Self-citation
Cited by
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 1,920
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
What we know about primary dysmenorrhea today: a critical review
Iacovides, S., Avidon, I., & Baker, F. C. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv039 · Cited by 1,022
The Methylation Effect in Medicinal Chemistry
Barreiro, E. J., Kümmerle, A. E., & Fraga, C. A. M. (2011) · Chemical Reviews · doi:10.1021/cr200060g · Cited by 1,017
Murakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., Ikeda, T., Fueki, M., Ueno, A., Oh-ishi, S., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003505200 · Cited by 964
Harirforoosh, S., Asghar, W., & Jamali, F. (2014) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3vw2f · Cited by 960
Korlach, J., Schwille, P., Webb, W. W., & Feigenson, G. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8461 · Cited by 850
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
Jüni, P., Nartey, L., Reichenbach, S., Sterchi, R., Dieppe, P. A., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17514-4 · Cited by 846
Hata, A. N., & Breyer, R. M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.003 · Cited by 840
Rao, P., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 773
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
Tegeder, I., Pfeilschifter, J., & Geisslinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0390rev · Cited by 747
Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?
Wallace, J. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00004.2008 · Cited by 716
NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2
Wallace, J. L., McKnight, W., Reuter, B. K., & Vergnolle, N. (2000) · Gastroenterology · doi:10.1053/gast.2000.16510 · Cited by 705
Ibuprofen: pharmacology, efficacy and safety
Rainsford, K. D. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-0016-x · Cited by 667
Cyclooxygenase inhibitors – current status and future prospects
Dannhardt, G., & Kiefer, W. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01197-7 · Cited by 657
Mechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 614
Self-citationDiclofenac: an update on its mechanism of action and safety profile
Gan, T. J. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.486301 · Cited by 600
Osteoarthritis — an untreatable disease?
Wieland, H. A., Michaelis, M., Kirschbaum, B. J., & Rudolphi, K. A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1693 · Cited by 585
Acetaminophen for osteoarthritis
Towheed, T., Maxwell, L., Judd, M., Catton, M., Hochberg, M. C., & Wells, G. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004257.pub2 · Cited by 563
Cyclo-Oxygenase 2 Function Is Essential for Bone Fracture Healing
Simon, A. M., Manigrasso, M. B., & O'Connor, J. P. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.963 · Cited by 530
Voilley, N., de Weille, J., Mamet, J., & Lazdunski, M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08026.2001 · Cited by 528
Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology
Altman, R., Bosch, B., Brune, K., Patrignani, P., & Young, C. (2015) · Drugs · doi:10.1007/s40265-015-0392-z · Cited by 493
Kinin receptors in pain and inflammation
Couture, R., Harrisson, M., Vianna, R. M., & Cloutier, F. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01318-8 · Cited by 472
Riendeau, D., Percival, M. D., Brideau, C., Charleson, S., Dubé, D., Ethier, D., Falgueyret, J.-P., Friesen, R. W., Gordon, R., Greig, G., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38776-2 · Cited by 460
The development of COX2 inhibitors
Flower, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1034 · Cited by 459
Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review
Bacchi, S., Palumbo, P., Sponta, A., & Coppolino, M. F. (2012) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152312803476255 · Cited by 433
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Itoh, K., Mochizuki, M., Ishii, Y., Ishii, T., Shibata, T., Kawamoto, Y., Kelly, V., Sekizawa, K., Uchida, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.36-45.2004 · Cited by 407
A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment
on behalf of the Rofecoxib Protocol 078 study group, Thal, L. J., Ferris, S. H., Kirby, L., Block, G. A., Lines, C. R., Yuen, E., Assaid, C., Nessly, M. L., Norman, B. A., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300690 · Cited by 402
Jüni, P., Rutjes, A. W., & Dieppe, P. A. (2002) · BMJ · doi:10.1136/bmj.324.7349.1287 · Cited by 396
Rofecoxib: No effect on Alzheimer’s disease in a 1-year, randomized, blinded, controlled study
Reines, S. A., Block, G. A., Morris, J. C., Liu, G., Nessly, M. L., Lines, C. R., Norman, B. A., & Baranak, C. C. (2004) · Neurology · doi:10.1212/wnl.62.1.66 · Cited by 385
Nonsteroidal Anti-inflammatory Drugs in Ophthalmology
Kim, S. J., Flach, A. J., & Jampol, L. M. (2010) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2009.07.005 · Cited by 383
Amir, M., & Shikha, K. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.02.008 · Cited by 373
Anti-inflammatory effects of aspirin and sodium salicylate
Amann, R., & Peskar, B. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01828-9 · Cited by 372
Nonsteroidal anti-inflammatory drug gastropathy
Hawkey, C. J. (2000) · Gastroenterology · doi:10.1053/gast.2000.9561 · Cited by 371
Patrono, C., Patrignani, P., & Rodríguez, L. A. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13418 · Cited by 364
Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors
Mollace, V., Muscoli, C., Masini, E., Cuzzocrea, S., & Salvemini, D. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.1 · Cited by 357
A Novel Mechanism of Cyclooxygenase-2 Inhibition Involving Interactions with Ser-530 and Tyr-385
Rowlinson, S. W., Kiefer, J. R., Prusakiewicz, J. J., Pawlitz, J. L., Kozak, K. R., Kalgutkar, A. S., Stallings, W. C., Kurumbail, R. G., & Marnett, L. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305481200 · Cited by 353
Zhang, J., Ding, E. L., & Song, Y. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60015 · Cited by 332
COX-2 Inhibitors and Cardiovascular Risk
Funk, C. D., & FitzGerald, G. A. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318157f72d · Cited by 330
The Role of Biomechanics and Inflammation in Cartilage Injury and Repair
Guilak, F., Fermor, B., Keefe, F. J., Kraus, V. B., Olson, S. A., Pisetsky, D. S., Setton, L. A., & Weinberg, J. B. (2004) · Clinical Orthopaedics & Related Research · doi:10.1097/01.blo.0000131233.83640.91 · Cited by 325
Clinical and pathologic perspectives on aspirin sensitivity and asthma
Stevenson, D. D., & Szczeklik, A. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.07.024 · Cited by 324
Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
Mitchell, J. A., & Warner, T. D. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702897 · Cited by 321
Self-citationLEES, P., LANDONI, M. F., Giraudel, J., & TOUTAIN, P. L. (2004) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2004.00617.x · Cited by 310
Takada, Y., Bhardwaj, A., Potdar, P., & Aggarwal, B. B. (2004) · Oncogene · doi:10.1038/sj.onc.1208169 · Cited by 310
Alberto García Rodríguez, L., & Hernández-Díaz, S. (2001) · Epidemiology · doi:10.1097/00001648-200109000-00018 · Cited by 307
COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease
Willoughby, D. A., Moore, A. R., & Colville-Nash, P. R. (2000) · The Lancet · doi:10.1016/s0140-6736(99)12031-2 · Cited by 298
Takeuchi, K., Smale, S., Premchand, P., Maiden, L., Sherwood, R., Thjodleifsson, B., Bjornsson, E., & Bjarnason, I. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00980-8 · Cited by 303
Bhandari, S. V., Bothara, K. G., Raut, M. K., Patil, A. A., Sarkate, A. P., & Mokale, V. J. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.11.014 · Cited by 302
Cyclooxygenase-3 (COX-3): Filling in the gaps toward a COX continuum?
Warner, T. D., & Mitchell, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222543099 · Cited by 302
Self-citationBiochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia
Fosslien, E. (2000) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360091174286 · Cited by 296
Zimmermann, N., Wenk, A., Kim, U., Kienzle, P., Weber, A.-A., Gams, E., Schrör, K., & Hohlfeld, T. (2003) · Circulation · doi:10.1161/01.cir.0000081770.51929.5a · Cited by 287
Drug repurposing: far beyond new targets for old drugs
Oprea, T. I., & Mestres, J. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9390-1 · Cited by 285
“for developing celecoxib (Celebrex®), which is an order of magnitude more potent on COX-2 compared to COX-1 [14].”
BackgroundFiorucci, S., Meli, R., Bucci, M., & Cirino, G. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00747-x · Cited by 285
Dormond, O., Foletti, A., Paroz, C., & Rüegg, C. (2001) · Nature Medicine · doi:10.1038/nm0901-1041 · Cited by 281
Mitchell, J. A., & Warner, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1929 · Cited by 279
Self-citationCyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice
Burleigh, M. E., Babaev, V. R., Oates, J. A., Harris, R. C., Gautam, S., Riendeau, D., Marnett, L. J., Morrow, J. D., Fazio, S., & Linton, M. F. (2002) · Circulation · doi:10.1161/01.cir.0000014927.74465.7f · Cited by 279
Zhang, X., Donnan, P. T., Bell, S., & Guthrie, B. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0673-8 · Cited by 278
Do Nonsteroidal Anti-Inflammatory Drugs Affect Bone Healing? A Critical Analysis
Pountos, I., Georgouli, T., Calori, G. M., & Giannoudis, P. V. (2012) · The Scientific World Journal · doi:10.1100/2012/606404 · Cited by 274
Kellenberger, S., & Schild, L. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009225 · Cited by 272
Postoperative Analgesic Effects of Celecoxib or Rofecoxib After Spinal Fusion Surgery
Reuben, S. S., & Connelly, N. R. (2000) · Anesthesia & Analgesia · doi:10.1097/00000539-200011000-00032 · Cited by 270
RetractedMamdani, M., Rochon, P. A., Juurlink, D. N., Kopp, A., Anderson, G. M., Naglie, G., Austin, P. C., & Laupacis, A. (2002) · BMJ · doi:10.1136/bmj.325.7365.624 · Cited by 270
Renal adverse effects of nonsteroidal anti-inflammatory drugs
Harirforoosh, S., & Jamali, F. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903311023 · Cited by 261
Upper Gastrointestinal Bleeding Associated with the Use of NSAIDs: Newer Versus Older Agents
Laporte, J.-R., Ib????ez, L., Vidal, X., Vendrell, L., & Leone, R. (2004) · Drug Safety · doi:10.2165/00002018-200427060-00005 · Cited by 256
Effects of Perioperative Antiinflammatory and Immunomodulating Therapy on Surgical Wound Healing
Busti, A. J., Hooper, J. S., Amaya, C. J., & Kazi, S. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.11.1566 · Cited by 221
Nociception in cyclooxygenase isozyme-deficient mice
Ballou, L. R., Botting, R. M., Goorha, S., Zhang, J., & Vane, J. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180319297 · Cited by 205
Self-citationMechanism of Acetaminophen Inhibition of Cyclooxygenase Isoforms
Ouellet, M., & Percival, M. D. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2232 · Cited by 166
Warner, T. D., & Mitchell, J. A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60137-3 · Cited by 166
Self-citationPreoperative stimulation of resolution and inflammation blockade eradicates micrometastases
Panigrahy, D., Gartung, A., Yang, J., Yang, H., Gilligan, M. M., Sulciner, M. L., Bhasin, S. S., Bielenberg, D. R., Chang, J., Schmidt, B. A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127282 · Cited by 132
Ayoub, S. S., Botting, R. M., Goorha, S., Colville-Nash, P. R., Willoughby, D. A., & Ballou, L. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404185101 · Cited by 104
Ayoub, S. S., Colville-Nash, P. R., Willoughby, D. A., & Botting, R. M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.061 · Cited by 79
Bonnefont, J., Alloui, A., Chapuy, E., Clottes, E., & Eschalier, A. (2003) · Anesthesiology · doi:10.1097/00000542-200310000-00034 · Cited by 74
Toxicological Property of Acetaminophen: The Dark Side of a Safe Antipyretic/Analgesic Drug?
Ishitsuka, Y., Kondo, Y., & Kadowaki, D. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00722 · Cited by 63
The effect of nimesulide on the indomethacin- and ethanol-induced gastric ulcer in rats
Süleyman, H., Akçay, F., & Altinkaynak, K. (2002) · Pharmacological Research · doi:10.1006/phrs.2001.0933 · Cited by 55
Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
Harris, R., Beebe, & Alshafie (2012) · Journal of Experimental Pharmacology · doi:10.2147/jep.s23826 · Cited by 43
Pro-inflammatory effect of freshly solubilized β-amyloid peptides in the brain
Paris, D., Townsend, K. P., Obregon, D. F., Humphrey, J., & Mullan, M. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00111-9 · Cited by 40
Bonnefont, J., Daulhac, L., Etienne, M., Chapuy, E., Mallet, C., Ouchchane, L., Deval, C., Courade, J.-P., Ferrara, M., Eschalier, A., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.025775 · Cited by 39
Metadata
- Authors
- Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-06-22
- Volume
- 96
- Issue
- 13
- Pages
- 7563-7568
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2038410983
- Cited by
- 1,519
- References
- 25
- FWCI
- 48.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.